Pure Global

A Study to Evaluate the Safety and Tolerability of Virtual Reality to Treat Gastroparesis - Trial NCT05079568

Access comprehensive clinical trial information for NCT05079568 through Pure Global AI's free database. This phase not specified trial is sponsored by Mayo Clinic and is currently Recruiting. The study focuses on Gastroparesis. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT05079568
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT05079568
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Study to Evaluate the Safety and Tolerability of Virtual Reality to Treat Gastroparesis
A Pilot Study to Assess the Safety, Tolerability and Efficacy of Virtual Reality for the Treatment of Gastroparesis

Study Focus

Gastroparesis

Oculus Go VR headset

Interventional

device

Sponsor & Location

Mayo Clinic

Jacksonville,Jacksonville, United States of America

Timeline & Enrollment

N/A

Oct 01, 2021

Dec 01, 2022

30 participants

Primary Outcome

Patient-reported adverse events

Summary

The purpose of this study is to determine if virtual reality therapy is safe and tolerable in
 treating gastroparesis.

ICD-10 Classifications

Attention to gastrostomy
Gastrostomy status
Other gastritis
Gastritis, unspecified
Gastric diverticulum

Data Source

ClinicalTrials.gov

NCT05079568

Device Trial